Tweet
J Cutan Pathol
. 2020 Aug 3.
doi: 10.1111/cup.13830. Online ahead of print.
Perniosis during the COVID-19 pandemic: Negative Anti-SARS-CoV-2 Immunohistochemistry in Six Patients and Comparison to Perniosis Before the Emergence of SARS-CoV-2
Christine J Ko 1 2 , Malini Harigopal 2 , William Damsky 1 2 , Jeff R Gehlhausen 1 , Marcus Bosenberg 1 2 , Robert Patrignelli 1 , Jennifer M McNiff 1 2
Affiliations
- PMID: 32745281
- DOI: 10.1111/cup.13830
Abstract
Background: Acral inflammatory lesions that have some resemblance to idiopathic or autoimmune-associated perniosis (chilblains) have been described in multiple countries during the COVID-19 pandemic.
Methods: We examined histopathologic findings in six consecutive such cases from five patients received in mid-May to mid-June of 2020, evaluating immunohistochemical staining for the SARS-CoV-2 nucleocapsid protein. We compared these six cases to eight cases diagnosed as perniosis between January and June of 2019.
Results: Five of six lesions with perniosis-like histopathology during the COVID-19 pandemic had distinctive tight cuffing of lymphocytes; intravascular material was present in one case. SARS-CoV-2 immunohistochemical staining using an antibody directed at the nucleocapsid protein was negative in all six cases. Only one of eight specimens with microscopic findings of perniosis received prior to the COVID-19 pandemic had tightly cuffed perivascular lymphocytes, and none had obvious intravascular occlusion.
Conclusions: A tightly cuffed pattern of perivascular lymphocytes is a feature of perniosis during the COVID-19 pandemic. The absence of SARS-CoV-2 nucleocapsid protein in these cases suggests against the virus being directly present in these lesions. This article is protected by copyright. All rights reserved.
Keywords: COVID-19; SARS-CoV-2; chilblain lupus; chilblains; coronavirus; pandemic; perniosis.